Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study

Abstract Background Epidemiological studies are necessary to develop diagnostic standards for mental disorders. Therefore, this study investigated the prevalence of anxiety disorders, and its correlation with different substances used by patients diagnosed substance use disorder referred Iran Psychiatric Hospital located in Tehran, Iran. Two hundred ninety-two male aged 18–65 (Mean age = 36.11, SD 10.55) were recruited according available participant pool. Structured Clinical Interview DSM-V Axis I Disorders was investigate their simultaneous then correlations during past year before our considered. Based on clinical evaluation structured psychiatric interviews, we panic disorder, agoraphobia, social generalized disorder. Results revealed that most common type among subjects current study. Further investigations significantly correlated abuse cannabis ( r 0.116, p value 0.047), tramadol 0.205, < 0.001), LSD 0.197, 0.001). Moreover, 0.124, 0.035), opium 0.186, methadone 0.152, 0.010), 0.258, alcohol 0.133, 0.023), 0.123, 0.036), benzodiazepines 0.168, 0.004). The results indicated none as well agoraphobia. However, agoraphobia had intravenous injection main route administration 0.174, Conclusions Here supports notion co-occurrence disorders is relatively must be taken into consideration when assessing a patient following up treatment.